The Role of Mild Behavioral Impairment in the Clinical–Biological Continuum of Alzheimer′s Disease
Open Access
- 6 November 2026
- journal article
- editorial
- Published by MDPI AG in Swiss Archives of Neurology, Psychiatry and Psychotherapy
- Vol. 176 (3) , 20
Abstract
Alzheimer’s disease has recently been redefined as a complex clinical–biological entity by the International Working Group (IWG), and while the cognitive symptoms associated with the disease progression have been thoroughly investigated, subtle behavioral changes that precede functional decline have been less systematically explored. Mild Behavioral Impairment has recently emerged and been operationalized with a dedicated checklist (MBI-C) to identify individuals presenting later-life persistent behavioral changes that might represent the first clinical signs related to an underlying neurodegenerative process. Here, we review current evidence supporting MBI as a promising clinical marker along the Alzheimer’s disease (AD) continuum since its preclinical stages, and we call for further research to investigate the potential added clinical value of a more structured, systematic assessment of behavioral changes in individuals at risk of progression. We outline that a structured MBI assessment could therefore be integrated first into future research diagnostic frameworks and, once validated in real-world settings, into routine clinical workups. Assessing MBI could then become a cost-effective, non-invasive tool aiding in distinguishing early neurodegenerative from primarily psychiatric disorders.Keywords
This publication has 30 references indexed in Scilit:
- Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseJAMA Neurology, 2026
- Validating plasma biomarkers for distinguishing neurodegenerative and psychiatric disordersAlzheimer's & Dementia, 2026
- Exploring the association between mild behavioral impairment and plasma p‐tau217: Implications for early detection of Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2025
- Empirical Classification of Neuropsychiatric Symptoms and Association of Classes With Diagnostic Progression and Cognitive Decline in Mild Cognitive Impairment and Alzheimer’s Disease PopulationsBiological Psychiatry, 2025
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Functional connectivity and mild behavioral impairment in dementia‐free elderlyAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2023
- The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive ImpairmentThe American Journal of Geriatric Psychiatry, 2019
- Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older AdultsThe American Journal of Geriatric Psychiatry, 2019
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairmentAlzheimer's & Dementia, 2015